Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

UroStream

Home » UroStream » Page 13
Precision Integration, Intelligent Leadership — Prof. Ye Dingwei Highlights the 15th Shanghai Urologic Oncology Conference

Precision Integration, Intelligent Leadership — Prof. Ye Dingwei Highlights the 15th Shanghai Urologic Oncology Conference

Posted by By Mourabit Halima 2025.12.25
Editor’s Note: With sails raised and talents converging, the 15th Shanghai Urologic Oncology Academic Conference, hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of…
Read More
Professor Bo Dai Interprets the 2025 Expert Consensus on Full-Course Prostate Cancer Management | 15th Shanghai Urological Oncology Conference

Professor Bo Dai Interprets the 2025 Expert Consensus on Full-Course Prostate Cancer Management | 15th Shanghai Urological Oncology Conference

Posted by By Mourabit Halima 2025.12.25
Editor’s Note: The 15th Shanghai Urological Oncology Academic Conference, hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urological Oncology Committee of the Shanghai Anti-Cancer Association and Fudan…
Read More
Professor Yao Zhu: The Clinical Transformation Already Underway—and Yet to Come—with Radioligand Therapy in Prostate Cancer

Professor Yao Zhu: The Clinical Transformation Already Underway—and Yet to Come—with Radioligand Therapy in Prostate Cancer

Posted by By Peter W. PENG 2025.12.25
15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…
Read More
Professor Yiping Zhu: Female Radical Cystectomy with Pelvic Organ Preservation

Professor Yiping Zhu: Female Radical Cystectomy with Pelvic Organ Preservation

Posted by By Mourabit Halima 2025.12.25
15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…
Read More
On-site from ESMO Asia | Dr. Yongbing Cheng (Team of Professor Guo Hongqian):

On-site from ESMO Asia | Dr. Yongbing Cheng (Team of Professor Guo Hongqian):

Posted by By Peng Longmei 2025.12.18
“Fewer Cores Without Losing Accuracy” — A New Strategy of MRI-Targeted Biopsy Plus Ipsilateral Systematic Biopsy of the Index Lesion in Prostate Cancer Editor’s Note: Prostate cancer is one of…
Read More
Professor Wasilijiang·Wahafu: Targeted Therapy Plus Immunotherapy Redefines Advanced Urothelial Carcinoma Care with Multidisciplinary Support

Professor Wasilijiang·Wahafu: Targeted Therapy Plus Immunotherapy Redefines Advanced Urothelial Carcinoma Care with Multidisciplinary Support

Posted by By Mourabit Halima 2025.12.18
Editor’s Note: Advanced urothelial carcinoma is a highly aggressive malignancy associated with poor prognosis, posing a serious threat to patient survival and quality of life. In recent years, continuous breakthroughs…
Read More
On-site from ESMO Asia | Professor Liangyou Gu: Disitamab Vedotin Plus Immunotherapy Brings New Hope for Adjuvant Treatment of UTUC

On-site from ESMO Asia | Professor Liangyou Gu: Disitamab Vedotin Plus Immunotherapy Brings New Hope for Adjuvant Treatment of UTUC

Posted by By Mourabit Halima 2025.12.18
Editor’s Note The incidence of upper tract urothelial carcinoma (UTUC) in China is significantly higher than in Western countries. Although radical nephroureterectomy remains the gold standard for treatment, a substantial…
Read More
Professor Peng Zhang: The HOPE Program Paves the Way for Bladder-Preserving Care in Urothelial Carcinoma

Professor Peng Zhang: The HOPE Program Paves the Way for Bladder-Preserving Care in Urothelial Carcinoma

Posted by By Mourabit Halima 2025.12.18
Editor’s Note: From November 10–16, 2025, the 9th West China Urologic Oncology Tianfu Academic Conference and the 11th Academic Annual Meeting on Urologic and Male Genitourinary Tumors of the Sichuan…
Read More
Professor Yige Bao: Perioperative Vidicitamab Plus Immunotherapy Enables Kidney-Sparing Treatment in High-Risk UTUC

Professor Yige Bao: Perioperative Vidicitamab Plus Immunotherapy Enables Kidney-Sparing Treatment in High-Risk UTUC

Posted by By Peng Longmei 2025.12.14
Editor’s note: Upper tract urothelial carcinoma (UTUC) accounts for about 17.9% of all urothelial carcinomas (UC) in China. For high-risk UTUC, radical nephroureterectomy (RNU) is the standard surgical procedure, but…
Read More
NCCU 2025丨Prof. Shan Zheng: Piercing Through the Pink — How to Overcome Diagnostic and Prognostic Challenges in Eosinophilic Renal Tumors?

NCCU 2025丨Prof. Shan Zheng: Piercing Through the Pink — How to Overcome Diagnostic and Prognostic Challenges in Eosinophilic Renal Tumors?

Posted by By Mourabit Halima 2025.12.14
Editor’s note: The incidence of genitourinary cancers in China has continued to rise, with prostate, bladder, and kidney cancers ranking among the most common malignancies. Among them, eosinophilic renal tumors…
Read More

Posts pagination

Previous page 1 … 11 12 13 14 15 … 20 Next page
Recent Posts
  • Professor Gang Zhu: Prevention and Treatment of Urologic Tumors — Early Screening Is Key, Personalized Care Enhances Patient Experience
  • Bladder Preservation Strategies in MIBC | Yiping Zhu: New Approaches and Clinical Practice
  • ASCO GU Key Opinion Leaders | Michiel van der Heijden: ADC + Immunotherapy Reshapes Urothelial Carcinoma Treatment, Opening New Paths for Bladder Preservation and Personalized Care
  • ASCO GU Insights | Haige Chen: Breakthroughs in Bladder Cancer and the New Era of Precision Treatment
  • ASCO GU Insights | Professor Yonghong Li on Major Advances in Prostate Cancer and Their Clinical Value 
Recent Comments
    Archives
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top